- Home
- NEUE vs AKTX Comparison
NEUE vs AKTX Comparison
Compare NEUE & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUE
- AKTX
- Stock Information
- Founded
- NEUE 2015
- AKTX N/A
- Country
- NEUE United States
- AKTX United States
- Employees
- NEUE N/A
- AKTX N/A
- Industry
- NEUE
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- NEUE
- AKTX Health Care
- Exchange
- NEUE NYSE
- AKTX Nasdaq
- Market Cap
- NEUE 42.7M
- AKTX 34.7M
- IPO Year
- NEUE 2021
- AKTX N/A
- Fundamental
- Price
- NEUE $7.39
- AKTX $1.19
- Analyst Decision
- NEUE Hold
- AKTX
- Analyst Count
- NEUE 1
- AKTX 0
- Target Price
- NEUE $7.00
- AKTX N/A
- AVG Volume (30 Days)
- NEUE 86.8K
- AKTX 67.9K
- Earning Date
- NEUE 03-06-2025
- AKTX 02-15-2025
- Dividend Yield
- NEUE N/A
- AKTX N/A
- EPS Growth
- NEUE N/A
- AKTX N/A
- EPS
- NEUE N/A
- AKTX N/A
- Revenue
- NEUE $996,890,000.00
- AKTX N/A
- Revenue This Year
- NEUE N/A
- AKTX N/A
- Revenue Next Year
- NEUE $9.44
- AKTX N/A
- P/E Ratio
- NEUE $2.19
- AKTX N/A
- Revenue Growth
- NEUE N/A
- AKTX N/A
- 52 Week Low
- NEUE $3.79
- AKTX $0.90
- 52 Week High
- NEUE $16.59
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- NEUE 67.30
- AKTX 47.06
- Support Level
- NEUE $7.28
- AKTX $1.13
- Resistance Level
- NEUE $7.41
- AKTX $1.27
- Average True Range (ATR)
- NEUE 0.18
- AKTX 0.12
- MACD
- NEUE -0.01
- AKTX 0.03
- Stochastic Oscillator
- NEUE 51.22
- AKTX 44.92
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).